Monoclonal antibody treatments are essential for treating high-risk patients who do not respond to vaccines and can also provide passive immunity to immunocompromised individuals.

“we can give them the monoclonal and antibody treatment because what that does is it's like loading them up literally with a thousand times more antibodies than you would make in response to a vaccine and it helps you beat and control the virus”